The in vivo and in vitro experiments have demonstrated that MALAT1 may not only promote proliferation of triple negative BC cells, cancer development and metastasis, but also has negative correlations with the survival of patients with ER-negative HER-2 positive and triple negative BC in terms of its expression level [51]. Here, MALAT1 is linked to cancer.